These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6330551)

  • 1. Clonality of EBV-induced lymphoproliferative diseases in immune-deficient patients.
    Purtilo DT
    N Engl J Med; 1984 Jul; 311(3):191-2. PubMed ID: 6330551
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
    Purtilo DT
    Biomed Pharmacother; 1985; 39(2):52-8. PubMed ID: 2990590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunodeficiency as a factor in lymphomagenesis.
    Purtilo DT; Sakamoto K
    Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8).
    Chadburn A
    Semin Diagn Pathol; 2013 May; 30(2):113-29. PubMed ID: 23537912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of EBV hybridization in clinical and biological medicine.
    Morinet F
    Nouv Rev Fr Hematol (1978); 1989; 31(2):155-8. PubMed ID: 2549502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders.
    Iwatsuki K; Ohtsuka M; Harada H; Han G; Kaneko F
    Arch Dermatol; 1997 Sep; 133(9):1081-6. PubMed ID: 9301584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
    Young L; Alfieri C; Hennessy K; Evans H; O'Hara C; Anderson KC; Ritz J; Shapiro RS; Rickinson A; Kieff E
    N Engl J Med; 1989 Oct; 321(16):1080-5. PubMed ID: 2552313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U; Weiss M; Belohradsky BH
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
    Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M
    J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated lymphoproliferative eruption with progression to large granular lymphocytic leukaemia.
    Cho KH; Kim CW; Kwon OS; Yang SG; Park KC; Park MH; Cho HI; Kim JG
    Br J Dermatol; 1997 Sep; 137(3):426-30. PubMed ID: 9349343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral infections in immunocompromised children.
    Borkowsky W
    Pediatr Ann; 1984 Sep; 13(9):682-3, 686-7, 690-2. PubMed ID: 6093032
    [No Abstract]   [Full Text] [Related]  

  • 14. [Atypical immunoproliferative processes. Proposed nosographic classification, clinico-pathological forms, pathogenetic theories and relations with malignant lymphomas].
    Frizzera G
    Recenti Prog Med; 1979 Aug; 67(2):238-66. PubMed ID: 228362
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epstein-Barr-virus-induced lymphoproliferative diseases].
    Schuster V; Kreth HW
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states.
    Tinguely M; Vonlanthen R; Müller E; Dommann-Scherrer CC; Schneider J; Laissue JA; Borisch B
    Mod Pathol; 1998 Apr; 11(4):307-12. PubMed ID: 9578079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphoma and immunodepression. Particular lymphoproliferations induced by EBV].
    Raphael M
    Rev Prat; 1993 Apr; 43(7):861-3. PubMed ID: 8394028
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
    Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
    Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr virus: pathologic implications].
    Kafé H; Wechsler J; Gaulard P; Gosselin B
    Ann Pathol; 1998 Feb; 18(1):16-28. PubMed ID: 9551155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.